Jul 8, 2026 07:00AM
Jul 8, 2026 07:00AM
May 12, 2026 06:30AM
May 1, 2026 07:30AM
Mar 31, 2026 06:30AM
Mar 27, 2026 07:30AM
Feb 24, 2026 07:30AM Keenova presents plantar fibromatosis clinical data at ACFAS meeting
Feb 24, 2026 07:30AM
Feb 16, 2026 07:30AM
Jan 21, 2026 07:30AM
Oct 31, 2025 08:00AM
Sep 18, 2025 06:45AM
Sep 18, 2025 06:45AM
Jun 18, 2025 06:48AM Mallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
May 14, 2025 06:52AM
Apr 23, 2025 06:52AM
Nov 18, 2024 11:00AM
Nov 18, 2024 11:00AM
Oct 30, 2024 06:50AM
Oct 29, 2024 08:30AM
Oct 26, 2024 01:00PM Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024
Oct 10, 2024 06:52AM
Sep 17, 2024 06:50AM
Aug 6, 2024 06:35AM
Jun 5, 2024 06:45AM
May 18, 2024 07:00AM
Mar 26, 2024 04:01PM
Mar 11, 2024 06:52AM Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patient
Mar 1, 2024 08:50AM
Jan 22, 2024 06:53AM
Jan 22, 2024 06:52AM
Nov 1, 2023 06:45AM
Oct 26, 2023 06:53AM
Oct 26, 2023 06:53AM
Aug 9, 2023 06:48AM Mallinckrodt (MNK) Reports Q2, Reaffirms Full Year Guidance
Aug 9, 2023 06:45AM
Jun 15, 2023 06:52AM
Jun 1, 2023 06:52AM
Jun 1, 2023 06:52AM
May 8, 2023 06:54AM
May 8, 2023 06:52AM
May 5, 2023 06:52AM Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact Awards
Apr 10, 2023 06:53AM
Apr 10, 2023 06:53AM
Mar 21, 2023 06:54AM
Mar 21, 2023 06:53AM
Jan 23, 2023 05:43AM
Jan 22, 2023 02:00PM
Nov 8, 2022 06:45AM Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance
Nov 3, 2022 06:53AM

325,087 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All